Neurocrine Acquires Soleno for $2.9 Billion to Boost Rare Obesity Disorder Portfolio episode artwork

EPISODE · Apr 6, 2026 · 15 MIN

Neurocrine Acquires Soleno for $2.9 Billion to Boost Rare Obesity Disorder Portfolio

from AI Daily Pulse · host Healthcare Daily Pulse

Intelligence Brief:Neurocrine Acquires Soleno for $2.9 Billion to Boost Rare Obesity Disorder PortfolioGilead Acquires Ouro Medicines for $2.2 BillionExpanding Autoimmune PipelineCMS Finalizes Extensive Policy Changes for Medicare Advantage and Part D in 2027Hologic CEO Stephen MacMillan Retires Amid Blackstone and TPG Buyout ClosureHeidi Partners with R1 to Integrate AI-Powered Documentation with Revenue Cycle Management## Healthcare Daily Pulse: Rapid-Fire Q3 Market Shifts **Hosts:** * **Alex:** Skeptical Financial Analyst (Payor expert). Technical, critical, implementation-focused. * **Sam:** Optimistic Market Visionary (ROI/Competitive Strategy expert). Pragmatic but forward-looking. --- **(0:00 - 0:45) INTRO** **Alex:** Welcome back to Healthcare Daily Pulse, your rapid-fire dive into the financial and operational seismic shifts shaking the healthcare landscape. I'm Alex, dissecting the P&L impacts ...

Episode metadata supplied by the publisher feed · Published Apr 6, 2026

Embed this episode

NOW PLAYING

Neurocrine Acquires Soleno for $2.9 Billion to Boost Rare Obesity Disorder Portfolio

0:00 15:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of AI Daily Pulse?

This episode is 15 minutes long.

When was this AI Daily Pulse episode published?

This episode was published on April 6, 2026.

Can I download this AI Daily Pulse episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!